Amylyx Pharmaceuticals (AMLX) Enterprise Value: 3.006B

Amylyx Pharmaceuticals, Inc. (AMLX)

28.69 -0.51 (-1.75%) USD | NASDAQ | Nov 04, 14:57

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2022. Start Trial.

Date	Value
November 03, 2026	3.006B
November 02, 2026	2.877B
October 30, 2026	2.969B
October 29, 2026	2.949B
October 28, 2026	2.881B
October 27, 2026	2.906B
October 26, 2026	2.771B
October 23, 2026	2.784B
October 22, 2026	2.936B
October 21, 2026	2.988B
October 20, 2026	2.959B
October 19, 2026	2.798B
October 16, 2026	2.688B
October 15, 2026	2.834B
October 14, 2026	2.765B
October 13, 2026	2.745B
October 12, 2026	2.815B
October 09, 2026	2.888B
October 08, 2026	2.784B
October 07, 2026	2.809B
October 06, 2026	2.877B
October 05, 2026	2.848B
October 02, 2026	2.849B
October 01, 2026	2.882B
September 30, 2026	2.995B

Date	Value
September 29, 2026	3.015B
September 28, 2026	3.079B
September 25, 2026	3.039B
September 24, 2026	3.111B
September 23, 2026	3.163B
September 22, 2026	3.430B
September 21, 2026	3.362B
September 18, 2026	3.364B
September 17, 2026	3.534B
September 16, 2026	3.388B
September 15, 2026	3.446B
September 14, 2026	3.501B
September 11, 2026	3.276B
September 10, 2026	3.328B
September 09, 2026	3.363B
September 08, 2026	3.528B
September 04, 2026	3.552B
September 03, 2026	3.537B
September 02, 2026	3.596B
September 01, 2026	3.520B
August 31, 2026	3.513B
August 28, 2026	3.623B
August 27, 2026	3.895B
August 26, 2026	3.884B
August 25, 2026	3.926B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks